Proteome analysis of a human liver carcinoma cell line stably expressing hepatitis delta virus ribonucleoproteins

Journal of Proteomics

Volumn 72, Issue 4, 2009, Pages 616-627

  Mota, Sérgio ^a,b,c   Mendes, Marta ^a,c   Freitas, Natália ^a   Penque, Deborah ^b   Coelho, Ana V ^c,d   Cunha, Celso ^a  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^c INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^d UNIVERSITY OF ÉVORA   (Portugal)

Author keywords

2 DE; Hepatitis D virus; Liver; Proteome

Indexed keywords

BINDING PROTEIN; CLATHRIN; COMPLEMENTARY DNA; ENDOPEPTIDASE LA; HISTONE H1; LAMIN A; LAMIN C; PROTEOME; RIBONUCLEOPROTEIN; TRIOSEPHOSPHATE ISOMERASE;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; DOWN REGULATION; GENETIC TRANSFECTION; HEPATITIS DELTA VIRUS; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; VALIDATION PROCESS; VIRUS REPLICATION; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HEPATITIS DELTA VIRUS; HUMANS; LIVER NEOPLASMS; PROTEOME; RIBONUCLEOPROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VIRAL PROTEINS; VIRUS REPLICATION;

HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS;

EID: 63649126717     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2008.12.003     Document Type: Article

References (62)

1. Govindarajan S., Chin K.P., Redeker A.G., and Peters R.L. Fulminant B viral hepatitis: role of delta agent. Gastroenterology 86 (1984) 1417-1420
2. Jacobson I.M., Dienstag J.L., Werner B.G., Brettler D.B., Levine P.H., and Mushawar I.K. Epidemiology and clinical impact of hepatitis D virus infection. Hepatology 5 (1985) 188-191
3. Smedile A., Rizzetto M., and Gerin J. Advances in hepatitis D virus biology and disease. Prog Liver Dis 12 (1994) 157-175
4. Taylor J.M. Replication of the hepatitis delta virus: recent developments. Trends Microbiol 11 (2003) 185-190
5. Casey J.L., and Gerin J.L. Hepatitis delta virus RNA editing: specific modification of adenosine in the antigenomic RNA. J Virol 69 (1995) 7593-7600
6. Cheng Q., Jayan G.C., and Casey J.L. Differential inhibition of RNA editing in hepatitis delta virus genotype III by the short and long forms of hepatitis delta antigen. J Virol 77 (2003) 7786-7795
7. Huang Z.S., and Wu H.N. Identification and characterization of the RNA chaperone activity of hepatitis delta antigen peptides. J Biol Chem 273 41 (1998) 26455-26461
8. Yamaguchi Y., Filipovska J., Yano K., Furuya A., Inukai N., Narita T., et al. Stimulation of RNA polymerase II elongation by hepatitis delta antigen. Science 293 (2001) 124-127
9. Chang F.L., Chen P.J., Tu S.J., Wang C.J., and Chen D.S. The large form of hepatitis δ antigen is crucial for the assembly of hepatitis δ virus. Proc Natl Acad Sci U S A 88 (1991) 8490-8494
10. Brazas R., and Ganem D. A cellular homolog of hepatitis delta antigen: implications for viral replication and evolution. Science 274 (1996) 90-94
11. Greco-Stewart V.S., Thibault C.S.t.L., and Pelchat M. Binding of the polypyrimidine tract-binding protein-associated splicing factor (PSF) to the hepatitis delta virus RNA. Virology 356 (2006) 35-44
12. Lee C.H., Chang S.C., Chen C.J., and Chang M.F. The nucleolin binding activity of hepatitis delta antigen is associated with nucleolus targeting. J Biol Chem 273 (1998) 7650-7656
13. Wong S.K., and Lazinski D.W. Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1. Proc Natl Acad Sci U S A 99 23 (2002) 15118-15123
14. Chen C.W., Tsay Y.G., Wu H.L., Lee C.H., Chen D.S., and Chen P.J. The double-stranded RNA-activated kinase, PKR, can phosphorylate hepatitis D virus small delta antigen at functional serine and threonine residues. J Biol Chem 277 (2002) 33058-33067
15. Circle D.A., Neel O.D., Robertson H.D., Clarke P.A., and Mathews M.B. Surprising specificity of PKR binding to delta agent genomic RNA. RNA 3 (1997) 438-448
16. Yamaguchi Y., Inuka N., Narita T., Wada T., and Handa H. Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA. Mol Cell Biol 22 (2002) 2918-2927
17. Kuo M.Y.P., Goldberg J., Coates L., Mason W., Gerin J., and Taylor J. Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure and applications. J Virol 62 (1988) 1855-1861
18. Cheng D., Yang A., Thomas H., and Monjardino J. Characterization of stable hepatitis delta-expressing cell lines: effect of HDAg on cell growth. Prog Clin Biol Res 382 (1993) 149-153
19. Cunha C., Monjardino J., Chang D., Krause S., and Carmo-Fonseca M. Localization of hepatitis delta virus RNA in the nucleus of human cells. RNA 4 (1998) 680-693
20. Gudima S., Chang J., Moraleda G., Azvolinsky A., and Taylor J. Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA. J Virol 76 8 (2002) 3709-3719
21. Mota S., Mendes M., Penque D., Coelho A.V., and Cunha C. Changes in the proteome of Huh7 cells induced by transient expression of hepatitis D virus RNA and antigens. J Proteomics 71 (2008) 71-79
22. Kuo M.Y.P., Chao M., and Taylor J. Initiation of replication of the hepatitis delta virus genome from cloned DNA: role of the delta antigen. J Virol 63 (1989) 1945-1950
23. Saldanha J., Homer E., Goldin P., Thomas H.C., and Monjardino J. Cloning and expression of an immunodominant region of the hepatitis delta antigen. J Gen Virol 71 (1990) 471-475
24. Candiano G., Bruschi M., Musante L., Santucci L., Ghiggeri G.M., Carnemolla B., et al. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25 (2004) 1327-1333
25. Pandey A., Andersen J.S., and Mann M. Use of mass spectrometry to study signalling pathways. Sci STKE 37 (2000) PL1
26. Roxo-Rosa M., da Costa G., Luider T.M., Scholte B.J., Coelho A.V., Amaral M.D., et al. Proteomic analysis of nasal cells from cystic fibrosis patients and non-cystic fibrosis control individuals: search for novel biomarkers of cystic fibrosis lung disease. Proteomics 6 7 (2006) 2314-2325
27. Hermjakob H., Montecchi-Palazzi L., Lewington C., Mudali S., Kerrien S., Orchard S., et al. IntAct: an open source molecular interaction database. Nucleic Acids Res 32 (2004) D452-455
28. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13 11 (2003) 2498-2504
29. - ΔΔCt method. Methods 25 (2001) 402-408
30. Pruijn G.J., Thijssen J.P., Smith P.R., Williams D.G., and Van Venrooij W.J. Anti-La monoclonal antibodies recognizing epitopes within the RNA-binding domain of the La protein show differential capacities to immunoprecipitate RNA-associated La protein. Eur J Biochem 232 (1995) 611-619
31. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 23 (2006) 607-618
32. Walker J.E. Lysine residue 199 of human serum albumin is modified by acetylsalicylic acid. FEBS Lett 66 (1976) 173-175
33. Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., and Veenstra T.D. Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS Spectra. J Proteome Res 6 (2007) 4150-4162
34. Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., et al. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci U S A 101 (2004) 12130-12135
35. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald III E.R., Hurov K.E., Luo J., et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316 (2007) 1160-1166
36. Chung E.J., Sung Y.K., Farooq M., Kim Y., Im S., Tak W.Y., et al. Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray. Mol Cells 14 3 (2002) 382-387
37. Li H., Rauch T., Chen Z.X., Szabó P.E., Riggs A.D., and Pfeifer G.P. The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells. J Biol Chem 281 28 (2006) 19489-19500
38. Chang J., Gudima S.O., Tarn C., Nie X., and Taylor J.M. Development of a novel system to study hepatitis delta virus genome replication. J Virol 79 13 (2005) 8182-8188
39. Shaw G., Morse S., Ararat M., and Graham F.L. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16 8 (2002) 869-871
40. Tsagris E.M., Martínez de Alba A.E., Gozmanova M., and Kalantidis K. Viroids. Cell Microbiol 10 11 (2008) 2168-2179
41. Ellerman J.E., Brown C.K., de Vera M., Billiar T., Rubartelli A., and Lotze M.T. Masquerader: high mobility group box-1 and cancer. Clin Cancer Res 13 10 (2007) 2836-2848
42. Jaeschke H. Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 290 6 (2006) G1083-1088
43. Li J., and Lee A.S. Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med 6 1 (2006) 45-54
44. He D. Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ 13 (2006) 393-403
45. Orosz F., Oláh J., and Ovádl J. Triosephosphate isomerase deficiency: facts and doubts. IUBMB Life 58 12 (2006) 703-715
46. Fang C., Yi Z., Liu F., Lan S., Wang J., Lu H., et al. Proteome analysis of human liver carcinoma cells harboring hepatitis C virus subgenomic replicon. Proteomics 6 (2006) 519-527
47. Parana R., Kay A., Molinet F., Viana S., Silva L.K., Salcedo J.M., et al. HDV genotypes in the western Amazon region: a preliminary report. Am J Trop Med Hyg 75 3 (2006) 475-479
48. Petrak J., Ivanek R., Toman O., Cmejla R., Cmejlova J., Vyoral D., et al. Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 8 9 (2008) 1744-1749
49. Pilipenko E.V., Pestova T.V., Kolupaeva V.G., Khitrina E.V., et al. A cell cycle-dependent protein serves as a template specific translation initiation factor. Genes Dev 14 (2000) 2028-2045
50. Li J., and Lee A.S. Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med 6 1 (2006) 45-54
51. Chen C.W., Tsay Y.G., Wu H.L., Lee C.H., Chen D.S., and Chen P.J. The double-stranded RNA-activated kinase, PKR, can phosphorylate hepatitis D virus small delta antigen at functional serine and threonine residues. J Biol Chem 277 (2002) 33058-33067
52. Okada M., Jang S.W., and Ye K. Ebp1 association with nucleophosmin/b23 is essential for regulating cell proliferation and suppressing apoptosis. J Biol Chem 282 50 (2007) 36744-36754
53. Huang W.H., Yung B.Y., Syu W.J., and Lee Y.H. The nucleolar phosphoprotein B23 interacts with hepatitis delta antigens and modulates the hepatitis delta virus RNA replication. J Biol Chem 276 27 (2001) 25166-25175
54. Philipp T., Straub P., Durazzo M., Tukey R.H., and Manns M.P. Molecular analysis of autoantigens in hepatitis D. J Hepatol 22 1 Suppl. (1995) 132-135
55. Richardson R.T., Batova I.N., Widgren E.E., Zheng L.X., Whitfield M., Marzluff W.F., et al. Characterization of the histone H1-binding protein, NASP, as a cell cycle-regulated somatic protein. J Biol Chem 275 39 (2000) 30378-30386
56. Moradela G., and Taylor J. Host RNA polymerase requirements for transcription of the human hepatitis delta virus genome. J Virol 75 (2001) 10161-10169
57. Macnaughton T.B., Shi S.T., Modahl L.E., and Lai M.M. Rolling circle replication of hepatitis delta virus RNA is carried out by two different cellular RNA polymerases. J Virol 76 (2002) 3920-3927
58. Curry S., and Conte M.R. A terminal affair: 3'-end recognition by the human La protein. Trends Biochem Sci 31 6 (2006) 303-305
59. Gorgoni B., and Gray N.K. The roles of cytoplasmic poly(A)-binding proteins in regulating gene expression: A developmental perspective. Brief Funct Genomics Proteomics 3 2 (2004) 125-141
60. Malhi H., and Gores G.J. Cellular and molecular mechanisms of liver injury. Gastroenterology 134 6 (2008) 1641-1654
61. Goldsmith Z.G., and Dhanasekaran D.N. G protein regulation of MAPK networks. Oncogene 26 22 (2007) 3122-3142
62. Yeh J.J., and Der C.J. Targeting signal transduction in pancreatic cancer treatment. Expert Opin Ther Targets 11 5 (2007) 673-694